A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Clinical trial NCT02994953 · TERMINATED
Trial details
- NCT number
- NCT02994953
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2020-10-08
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.